SG10201913342UA - Compositions for use in treating tendon degeneration - Google Patents
Compositions for use in treating tendon degenerationInfo
- Publication number
- SG10201913342UA SG10201913342UA SG10201913342UA SG10201913342UA SG10201913342UA SG 10201913342U A SG10201913342U A SG 10201913342UA SG 10201913342U A SG10201913342U A SG 10201913342UA SG 10201913342U A SG10201913342U A SG 10201913342UA SG 10201913342U A SG10201913342U A SG 10201913342UA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- treating tendon
- tendon degeneration
- degeneration
- treating
- Prior art date
Links
- 230000007850 degeneration Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 210000002435 tendon Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/386—Ligaments, tendons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Botany (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
- Closures For Containers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662328396P | 2016-04-27 | 2016-04-27 | |
| US201662367377P | 2016-07-27 | 2016-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201913342UA true SG10201913342UA (en) | 2020-03-30 |
Family
ID=58709560
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201913342UA SG10201913342UA (en) | 2016-04-27 | 2017-04-26 | Compositions for use in treating tendon degeneration |
| SG11201809197XA SG11201809197XA (en) | 2016-04-27 | 2017-04-26 | Compositions for use in treating tendon degeneration |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809197XA SG11201809197XA (en) | 2016-04-27 | 2017-04-26 | Compositions for use in treating tendon degeneration |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10441677B2 (https=) |
| EP (1) | EP3448394B1 (https=) |
| JP (1) | JP6826657B2 (https=) |
| KR (1) | KR20190009303A (https=) |
| CN (1) | CN109562124A (https=) |
| AU (1) | AU2017257956B2 (https=) |
| CA (1) | CA3021764C (https=) |
| IL (1) | IL262507B (https=) |
| MX (1) | MX375382B (https=) |
| NZ (1) | NZ747413A (https=) |
| RU (1) | RU2018141386A (https=) |
| SG (2) | SG10201913342UA (https=) |
| TW (2) | TWI755392B (https=) |
| WO (1) | WO2017189723A1 (https=) |
| ZA (1) | ZA201807136B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018399962B2 (en) | 2018-01-02 | 2024-11-14 | Cartiheal (2009) Ltd. | Implantation tool and protocol for optimized solid substrates promoting cell and tissue growth |
| JP2024006681A (ja) * | 2022-07-04 | 2024-01-17 | 学校法人近畿大学 | 生体材料 |
| KR102940883B1 (ko) * | 2022-12-27 | 2026-03-17 | 차의과학대학교 산학협력단 | 비타민 d를 포함하는 건병증 또는 근육손상 치료용 히알루론산 하이드로겔계 약물 전달 시스템 및 이의 제조방법 |
| WO2025096427A1 (en) * | 2023-10-29 | 2025-05-08 | Brown David Donaldson | Methods for treating lower back pain with hyaluronic acid |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2946819A (en) | 1958-04-14 | 1960-07-26 | Gen Aniline & Film Corp | Process of producing carbodimides |
| DE1156401B (de) | 1960-05-24 | 1963-10-31 | Bayer Ag | Verfahren zur Herstellung von Carbodiimiden |
| DE1149712B (de) | 1961-11-14 | 1963-06-06 | Bayer Ag | Verfahren zur Herstellung von Carbodiimiden |
| US3644456A (en) | 1964-08-12 | 1972-02-22 | Upjohn Co | Di((isocyanatobenzyl)-phenyl) carbodiimides and preparation of organic carbodiimides |
| US3972933A (en) | 1974-05-28 | 1976-08-03 | Monsanto Company | Preparation of carbodiimides from ureas by dehydration |
| GB1476088A (en) | 1975-04-03 | 1977-06-10 | Ici Ltd | Carbodiimides |
| DE2556760A1 (de) | 1975-12-17 | 1977-06-30 | Hoechst Ag | Verfahren zur herstellung von carbodiimiden |
| GB1584153A (en) | 1976-09-22 | 1981-02-04 | Ici Ltd | Carbodimides |
| US4066629A (en) | 1976-10-28 | 1978-01-03 | Celanese Corporation | Process for preparing carbodiimides utilizing a phosphonium salt catalyst |
| US4098973A (en) | 1977-01-31 | 1978-07-04 | The Upjohn Company | Compounds and process |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
| DE69809892T2 (de) | 1997-04-04 | 2003-08-28 | Fidia Advanced Biopolymers S.R.L., Brindisi | N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung |
| ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
| ATE243049T1 (de) | 1999-12-09 | 2003-07-15 | Biosyntech Canada Inc | Mineral-polymer hybrid-zusammensetzung |
| ATE392907T1 (de) | 2000-07-28 | 2008-05-15 | Anika Therapeutics Inc | Bioabsorbierbare kompositmaterialien aus derivatisierter hyaluronsäure |
| IT1317359B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e |
| IT1317358B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Derivati cross-linkati dell'acido ialuronico. |
| ATE312076T1 (de) | 2001-02-22 | 2005-12-15 | Anika Therapeutics Inc | Thiol-modifizierte hyaluronan-derivate |
| US20060272221A1 (en) | 2001-11-29 | 2006-12-07 | Treibacher Schleifmittel Gmbh | Al2O3 and ZrO2 based abrasive grain, method for the production and use thereof |
| WO2003072157A1 (en) | 2002-02-21 | 2003-09-04 | Encelle, Inc. | Immobilized bioactive hydrogel matrices as surface coatings |
| ITPD20020064A1 (it) | 2002-03-12 | 2003-09-12 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem |
| ES2260616T3 (es) | 2002-06-19 | 2006-11-01 | Dr.H.C. Robert Mathys Stiftung | Cemento hidraulico con base de fosfato de calcio destinado a uso quirurgico. |
| US8455458B2 (en) * | 2002-10-16 | 2013-06-04 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage |
| DE10257554B4 (de) | 2002-12-10 | 2008-04-10 | Treibacher Schleifmittel Gmbh | Schleifkörner mit einer Ummantelung aus einem wässrigen Bindemittel und einer komplexen feinkörnigen Oxidverbindung, Verfahren zur Behandlung derartiger Schleifkörner sowie ihre Verwendung für kunstharzgebundene Schleifmittel |
| EP1677806B1 (en) | 2003-10-09 | 2008-11-19 | Robert John Petrella | Methods for treating acute and overuse sprain and strain using hyaluronic acid |
| US8124120B2 (en) | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
| CA2633957A1 (en) | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
| EP1891984A1 (en) | 2006-08-24 | 2008-02-27 | Graftys | Macroporous and highly resorbable apatitic calcium-phosphate cement |
| IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
| AU2010298484B2 (en) * | 2009-09-23 | 2014-09-25 | Glenpharma Ab | Compositions and methods for inducing or enhancing connective tissue repair |
| CN102811622A (zh) * | 2010-02-22 | 2012-12-05 | 生物模拟治疗公司 | 用于治疗腱病的血小板衍生生长因子组合物和方法 |
| CA2838816C (en) | 2011-06-09 | 2017-08-15 | Zimmer Gmbh | Instruments and devices for subchondral joint repair |
| EP2827914B1 (en) | 2012-03-22 | 2019-05-08 | TRB Chemedica International S.A. | Method for repair of ligament or tendon |
| PT2900247T (pt) * | 2012-09-26 | 2018-03-28 | Bone Therapeutics Sa | Composições contendo plasma tratado com dissolventes/detergentes e ácido hialurónico para serem utilizadas no tratamento de distúrbios músculo-esqueléticos |
| JP6721514B2 (ja) * | 2014-02-20 | 2020-07-15 | オルト リジェネレイティヴ テクノロジーズ インク．Ｏｒｔｈｏ Ｒｅｇｅｎｅｒａｔｉｖｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | 多血小板血漿と混合し、組織修復のためのインプラントを形成するための凍結乾燥ポリマー組成物及び／又は治療用関節内注射のための組成物 |
-
2017
- 2017-04-26 RU RU2018141386A patent/RU2018141386A/ru unknown
- 2017-04-26 MX MX2018012964A patent/MX375382B/es active IP Right Grant
- 2017-04-26 EP EP17723815.1A patent/EP3448394B1/en active Active
- 2017-04-26 CA CA3021764A patent/CA3021764C/en active Active
- 2017-04-26 WO PCT/US2017/029635 patent/WO2017189723A1/en not_active Ceased
- 2017-04-26 SG SG10201913342UA patent/SG10201913342UA/en unknown
- 2017-04-26 US US15/497,577 patent/US10441677B2/en active Active
- 2017-04-26 JP JP2019508158A patent/JP6826657B2/ja active Active
- 2017-04-26 KR KR1020187033872A patent/KR20190009303A/ko not_active Ceased
- 2017-04-26 CN CN201780039455.6A patent/CN109562124A/zh active Pending
- 2017-04-26 AU AU2017257956A patent/AU2017257956B2/en active Active
- 2017-04-26 NZ NZ747413A patent/NZ747413A/en unknown
- 2017-04-26 SG SG11201809197XA patent/SG11201809197XA/en unknown
- 2017-04-27 TW TW106114071A patent/TWI755392B/zh active
- 2017-04-27 TW TW109130386A patent/TW202114712A/zh unknown
-
2018
- 2018-10-22 IL IL262507A patent/IL262507B/en active IP Right Grant
- 2018-10-25 ZA ZA2018/07136A patent/ZA201807136B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018141386A3 (https=) | 2020-05-27 |
| EP3448394A1 (en) | 2019-03-06 |
| AU2017257956A1 (en) | 2018-11-15 |
| CN109562124A (zh) | 2019-04-02 |
| WO2017189723A1 (en) | 2017-11-02 |
| TW201739457A (zh) | 2017-11-16 |
| SG11201809197XA (en) | 2018-11-29 |
| ZA201807136B (en) | 2021-05-26 |
| MX375382B (es) | 2025-03-06 |
| RU2018141386A (ru) | 2020-05-27 |
| CA3021764A1 (en) | 2017-11-02 |
| WO2017189723A9 (en) | 2018-06-28 |
| AU2017257956B2 (en) | 2019-11-07 |
| KR20190009303A (ko) | 2019-01-28 |
| EP3448394C0 (en) | 2023-09-13 |
| CA3021764C (en) | 2021-01-19 |
| TW202114712A (zh) | 2021-04-16 |
| US10441677B2 (en) | 2019-10-15 |
| JP6826657B2 (ja) | 2021-02-03 |
| JP2019516784A (ja) | 2019-06-20 |
| EP3448394B1 (en) | 2023-09-13 |
| MX2018012964A (es) | 2019-06-10 |
| IL262507A (en) | 2018-12-31 |
| IL262507B (en) | 2020-10-29 |
| US20170326271A1 (en) | 2017-11-16 |
| NZ747413A (en) | 2020-09-25 |
| TWI755392B (zh) | 2022-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3490582T3 (pl) | Kompozycje do zastosowania w leczeniu mielofibrozy | |
| IL258288B (en) | Hair strengthening compound and hair strengthening method | |
| ZA201706681B (en) | Compositions and methods for treating anemia | |
| PL3160234T3 (pl) | Kompozycie do stosowania w profilaktyce i leczeniu wzrostu biofilmu na oczach, na rękach lub stopach | |
| IL259992B (en) | Compounds for use in methods for treating increased sensitivity to pain | |
| IL251759A0 (en) | Preparations and methods for treating insomnia | |
| PT4215527T (pt) | Composições e métodos para tratar a degradação retinal | |
| IL271256A (en) | Preparations and methods for the treatment of teopathy | |
| SG11201606101WA (en) | Compositions and methods for treating and preventing macular degeneration | |
| PL3402575T4 (pl) | Sposoby i kompozycje do traktowania zniszczonych włosów | |
| IL250980A0 (en) | Mucolytic agents for use in the treatment of pulmonary sarcoidosis | |
| ES3062284T3 (en) | Compositions for use in treating psychotic disorders | |
| DK3250213T3 (en) | Compositions containing arsenic for use in methods of treatment | |
| ZA201807136B (en) | Compositions for use in treating tendon degeneration | |
| IL269743A (en) | Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions | |
| IL250114B (en) | Methods and compositions for the treatment of HIV-related diseases | |
| ZA201605109B (en) | Compositions and methods for treating neutropenia | |
| IL246637A0 (en) | Preparations and methods for the treatment of intracerebral hemorrhage | |
| GB2560769B (en) | Compounds and compositions for use in treating psoriasis | |
| GB201511447D0 (en) | Compositions and methods for treating biofilms | |
| GB201511051D0 (en) | Compositions and methods for treating biofilms | |
| GB201521083D0 (en) | Compositions for treatment and methods thereof | |
| GB201407949D0 (en) | Compositions and methods for treating biofilms |